Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Raw Materials (2019 - 2025)

Historic Raw Materials for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $4.3 million.

  • Pulmonx's Raw Materials rose 2629.08% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 2629.08%. This contributed to the annual value of $3.4 million for FY2024, which is 1648.43% up from last year.
  • Latest data reveals that Pulmonx reported Raw Materials of $4.3 million as of Q3 2025, which was up 2629.08% from $3.9 million recorded in Q2 2025.
  • Over the past 5 years, Pulmonx's Raw Materials peaked at $4.3 million during Q3 2025, and registered a low of $2.9 million during Q3 2023.
  • Its 5-year average for Raw Materials is $3.5 million, with a median of $3.4 million in 2024.
  • In the last 5 years, Pulmonx's Raw Materials plummeted by 2345.55% in 2023 and then surged by 3001.32% in 2025.
  • Quarter analysis of 5 years shows Pulmonx's Raw Materials stood at $3.7 million in 2021, then increased by 2.19% to $3.8 million in 2022, then decreased by 23.46% to $2.9 million in 2023, then grew by 16.48% to $3.4 million in 2024, then increased by 24.96% to $4.3 million in 2025.
  • Its Raw Materials was $4.3 million in Q3 2025, compared to $3.9 million in Q2 2025 and $3.4 million in Q1 2025.